TRDA
Entrada Therapeutics Inc
6.20$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | -371.3% | 108.4% | -19.7% | -505.5% | |
| – | – | – | 7.5% | 2.2% | 1.8% | 16.1% | |
| – | – | – | 39.2% | 10.2% | 8.5% | 77.1% | |
| – | – | – | 39.8% | – | – | – | |
| – | – | – | -44.0% | 105.7% | -56.4% | -18.9% | |
| – | – | – | 11.4% | 4.4% | 1.5% | 4.1% | |
| – | – | – | -588.5% | -107.3% | -13.2% | 459.5% | |
| – | – | – | 1.1% | 0.3% | 0.3% | 1.8% | |
| – | – | – | 1.9% | 16.3% | 48.8% | 3.5% | |
| – | – | – | -973.5% | 17.4% | 15.9% | -42.6% | |
| – | – | – | -382.7% | 104.0% | -21.2% | -509.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.